{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T17:41:01Z","timestamp":1725990061467},"publisher-location":"Cham","reference-count":67,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319905778"},{"type":"electronic","value":"9783319905785"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-90578-5_10","type":"book-chapter","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T14:30:33Z","timestamp":1536071433000},"page":"147-157","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fibrosis in Ulcerative Colitis"],"prefix":"10.1007","author":[{"given":"Fernando","family":"Magro","sequence":"first","affiliation":[]},{"given":"Tatiana","family":"Ant\u00f3nio","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,9,5]]},"reference":[{"issue":"Suppl 2","key":"10_CR1","doi-asserted-by":"publisher","first-page":"S168","DOI":"10.1002\/ibd.20598","volume":"14","author":"K Geboes","year":"2008","unstructured":"Geboes K. What histologic features best differentiate Crohn\u2019s disease from ulcerative colitis? Inflamm Bowel Dis. 2008;14(Suppl 2):S168\u20139.","journal-title":"Inflamm Bowel Dis"},{"issue":"18","key":"10_CR2","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMra1102942","volume":"365","author":"S Danese","year":"2011","unstructured":"Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011;365(18):1713\u201325.","journal-title":"N Engl J Med"},{"issue":"8","key":"10_CR3","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3109\/00365521.2015.1014407","volume":"50","author":"J Burisch","year":"2015","unstructured":"Burisch J, Munkholm P. The epidemiology of inflammatory bowel disease. Scand J Gastroenterol. 2015;50(8):942\u201351.","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1055\/s-2004-823067","volume":"17","author":"CB Whitlow","year":"2004","unstructured":"Whitlow CB. Ulcerative proctitis. Clin Colon Rectal Surg. 2004;17(1):21\u20137.","journal-title":"Clin Colon Rectal Surg"},{"issue":"4-5","key":"10_CR5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.autrev.2014.01.028","volume":"13","author":"K Conrad","year":"2014","unstructured":"Conrad K, Roggenbuck D, Laass MW. Diagnosis and classification of ulcerative colitis. Autoimmun Rev. 2014;13(4-5):463\u20136.","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10_CR6","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.mayocp.2014.07.002","volume":"89","author":"JD Feuerstein","year":"2014","unstructured":"Feuerstein JD, Cheifetz AS. Ulcerative colitis: epidemiology, diagnosis, and management. Mayo Clin Proc. 2014;89(11):1553\u201363.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10_CR7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/ajg.2009.727","volume":"105","author":"A Kornbluth","year":"2010","unstructured":"Kornbluth A, Sachar DB, Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010;105(3):501\u201323; quiz 524.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10_CR8","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","volume":"140","author":"J Cosnes","year":"2011","unstructured":"Cosnes J, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140(6):1785\u201394.","journal-title":"Gastroenterology"},{"issue":"9","key":"10_CR9","first-page":"1323","volume":"76","author":"RC Langan","year":"2007","unstructured":"Langan RC, et al. Ulcerative colitis: diagnosis and treatment. Am Fam Physician. 2007;76(9):1323\u201330.","journal-title":"Am Fam Physician"},{"issue":"10","key":"10_CR10","first-page":"1283","volume":"17","author":"G Latella","year":"2013","unstructured":"Latella G, et al. Can we prevent, reduce or reverse intestinal fibrosis in IBD? Eur Rev Med Pharmacol Sci. 2013;17(10):1283\u2013304.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"30","key":"10_CR11","doi-asserted-by":"publisher","first-page":"4819","DOI":"10.3748\/wjg.v12.i30.4819","volume":"12","author":"KS Rothfuss","year":"2006","unstructured":"Rothfuss KS, Stange EF, Herrlinger KR. Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol. 2006;12(30):4819\u201331.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10_CR12","first-page":"235","volume":"7","author":"JS Levine","year":"2011","unstructured":"Levine JS, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol. 2011;7(4):235\u201341.","journal-title":"Gastroenterol Hepatol"},{"issue":"1","key":"10_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/01.MIB.0000437615.98881.31","volume":"20","author":"LA Johnson","year":"2014","unstructured":"Johnson LA, et al. Novel Rho\/MRTF\/SRF inhibitors block matrix-stiffness and TGF-\u03b2\u2013induced fibrogenesis in human colonic myofibroblasts. Inflamm Bowel Dis. 2014;20(1):154\u201365.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","volume":"142","author":"NA Molodecky","year":"2012","unstructured":"Molodecky NA, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46\u201354 e42; quiz e30.","journal-title":"Gastroenterology"},{"key":"10_CR15","first-page":"237","volume":"5","author":"A Ponder","year":"2013","unstructured":"Ponder A, Long MD. A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol. 2013;5:237\u201347.","journal-title":"Clin Epidemiol"},{"issue":"8","key":"10_CR16","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1111\/jgh.12616","volume":"29","author":"H Takahashi","year":"2014","unstructured":"Takahashi H, et al. Second peak in the distribution of age at onset of ulcerative colitis in relation to smoking cessation. J Gastroenterol Hepatol. 2014;29(8):1603\u20138.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"10_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/MOG.0000000000000363","volume":"33","author":"G Latella","year":"2017","unstructured":"Latella G, Rieder F. Intestinal fibrosis: ready to be reversed. Curr Opin Gastroenterol. 2017;33(4):239\u201345.","journal-title":"Curr Opin Gastroenterol"},{"issue":"7","key":"10_CR18","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/gut.33.7.938","volume":"33","author":"V Gumaste","year":"1992","unstructured":"Gumaste V, Sachar DB, Greenstein AJ. Benign and malignant colorectal strictures in ulcerative colitis. Gut. 1992;33(7):938\u201341.","journal-title":"Gut"},{"issue":"1","key":"10_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000321618","volume":"84","author":"G Rogler","year":"2011","unstructured":"Rogler G. Pathogenesis of strictures in ulcerative colitis: a field to explore. Digestion. 2011;84(1):10\u20131.","journal-title":"Digestion"},{"issue":"1","key":"10_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000320773","volume":"84","author":"M Yamagata","year":"2011","unstructured":"Yamagata M, et al. Submucosal fibrosis and basic-fibroblast growth factor-positive neutrophils correlate with colonic stenosis in cases of ulcerative colitis. Digestion. 2011;84(1):12\u201321.","journal-title":"Digestion"},{"issue":"9853","key":"10_CR21","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","volume":"380","author":"I Ord\u00e1s","year":"2012","unstructured":"Ord\u00e1s I, et al. Ulcerative colitis. Lancet. 2012;380(9853):1606\u201319.","journal-title":"Lancet"},{"issue":"10","key":"10_CR22","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.crohns.2014.03.008","volume":"8","author":"G Latella","year":"2014","unstructured":"Latella G, et al. Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD. J Crohns Colitis. 2014;8(10):1147\u201365.","journal-title":"J Crohns Colitis"},{"issue":"7","key":"10_CR23","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/ibd.20380","volume":"14","author":"ME Spehlmann","year":"2008","unstructured":"Spehlmann ME, et al. Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study. Inflamm Bowel Dis. 2008;14(7):968\u201376.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10_CR24","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1084\/jem.180.6.2359","volume":"180","author":"JD Taurog","year":"1994","unstructured":"Taurog JD, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med. 1994;180(6):2359\u201364.","journal-title":"J Exp Med"},{"issue":"7351","key":"10_CR25","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature10209","volume":"474","author":"B Khor","year":"2011","unstructured":"Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474(7351):307\u201317.","journal-title":"Nature"},{"issue":"4","key":"10_CR26","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nrgastro.2009.31","volume":"6","author":"F Rieder","year":"2009","unstructured":"Rieder F, Fiocchi C. Intestinal fibrosis in IBD\u2014a dynamic, multifactorial process. Nat Rev Gastroenterol Hepatol. 2009;6(4):228\u201335.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"10_CR27","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/ecco-jcc\/jjw076","volume":"10","author":"C Ippolito","year":"2016","unstructured":"Ippolito C, et al. Fibrotic and vascular remodelling of colonic wall in patients with active ulcerative colitis. J Crohns Colitis. 2016;10(10):1194\u2013204.","journal-title":"J Crohns Colitis"},{"issue":"11","key":"10_CR28","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1093\/ecco-jcc\/jjv142","volume":"9","author":"G Latella","year":"2015","unstructured":"Latella G, Rieder F. Time to look underneath the surface: ulcerative colitis-associated fibrosis. J Crohns Colitis. 2015;9(11):941\u20132.","journal-title":"J Crohns Colitis"},{"issue":"11","key":"10_CR29","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/ecco-jcc\/jjv133","volume":"9","author":"JR Bruyn de","year":"2015","unstructured":"de Bruyn JR, et al. Development of fibrosis in acute and longstanding ulcerative colitis. J Crohns Colitis. 2015;9(11):966\u201372.","journal-title":"J Crohns Colitis"},{"issue":"1","key":"10_CR30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/jcmm.12457","volume":"19","author":"M Manetti","year":"2015","unstructured":"Manetti M, et al. Telocytes are reduced during fibrotic remodelling of the colonic wall in ulcerative colitis. J Cell Mol Med. 2015;19(1):62\u201373.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00423-011-0789-4","volume":"397","author":"J Maul","year":"2012","unstructured":"Maul J, Zeitz M. Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations. Langenbeck\u2019s Arch Surg. 2012;397(1):1\u201310.","journal-title":"Langenbeck\u2019s Arch Surg"},{"issue":"7","key":"10_CR32","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/ibd.22839","volume":"18","author":"J Torres","year":"2012","unstructured":"Torres J, et al. Ulcerative colitis as a progressive disease: the forgotten evidence. Inflamm Bowel Dis. 2012;18(7):1356\u201363.","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"10_CR33","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1097\/MIB.0000000000000080","volume":"20","author":"IO Gordon","year":"2014","unstructured":"Gordon IO, et al. Fibrosis in ulcerative colitis: mechanisms, features, and consequences of a neglected problem. Inflamm Bowel Dis. 2014;20(11):2198\u2013206.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10_CR34","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/gut.2006.090456","volume":"56","author":"F Rieder","year":"2007","unstructured":"Rieder F, et al. Wound healing and fibrosis in intestinal disease. Gut. 2007;56(1):130\u20139.","journal-title":"Gut"},{"issue":"1-2","key":"10_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000449079","volume":"35","author":"D Bettenworth","year":"2017","unstructured":"Bettenworth D, Rieder F. Pathogenesis of intestinal fibrosis in inflammatory bowel disease and perspectives for therapeutic implication. Dig Dis. 2017;35(1-2):25\u201331.","journal-title":"Dig Dis"},{"issue":"28","key":"10_CR36","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.3748\/wjg.v18.i28.3635","volume":"18","author":"S Speca","year":"2012","unstructured":"Speca S, et al. Cellular and molecular mechanisms of intestinal fibrosis. World J Gastroenterol. 2012;18(28):3635\u201361.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214(2):199\u2013210.","journal-title":"J Pathol"},{"issue":"1","key":"10_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3109\/00365521.2014.968863","volume":"50","author":"G Latella","year":"2015","unstructured":"Latella G, et al. Mechanisms of initiation and progression of intestinal fibrosis in IBD. Scand J Gastroenterol. 2015;50(1):53\u201365.","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10_CR39","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/ibd.21812","volume":"18","author":"LA Johnson","year":"2012","unstructured":"Johnson LA, et al. Intestinal fibrosis is reduced by early elimination of inflammation in a mouse model of IBD: impact of a \u201cTop-Down\u201d approach to intestinal fibrosis in mice. Inflamm Bowel Dis. 2012;18(3):460\u201371.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10_CR40","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.gastro.2005.05.002","volume":"129","author":"F Heller","year":"2005","unstructured":"Heller F, et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology. 2005;129(2):550\u201364.","journal-title":"Gastroenterology"},{"issue":"10","key":"10_CR41","doi-asserted-by":"publisher","first-page":"E135","DOI":"10.1002\/ibd.21816","volume":"17","author":"G Fonseca-Camarillo","year":"2011","unstructured":"Fonseca-Camarillo G, et al. Interleukin 17 gene and protein expression are increased in patients with ulcerative colitis. Inflamm Bowel Dis. 2011;17(10):E135\u20136.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10_CR42","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.2353\/ajpath.2010.100378","volume":"177","author":"J Sponheim","year":"2010","unstructured":"Sponheim J, et al. Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. Am J Pathol. 2010;177(6):2804\u201315.","journal-title":"Am J Pathol"},{"issue":"3","key":"10_CR43","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/00054725-200108000-00008","volume":"7","author":"IC Lawrance","year":"2001","unstructured":"Lawrance IC, Maxwell L, Doe W. Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease. Inflamm Bowel Dis. 2001;7(3):226\u201336.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10_CR44","doi-asserted-by":"publisher","first-page":"G809","DOI":"10.1152\/ajpgi.00057.2002","volume":"283","author":"JG Simmons","year":"2002","unstructured":"Simmons JG, et al. IGF-I and TGF-beta1 have distinct effects on phenotype and proliferation of intestinal fibroblasts. Am J Physiol Gastrointest Liver Physiol. 2002;283(3):G809\u201318.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"43","key":"10_CR45","doi-asserted-by":"publisher","first-page":"36099","DOI":"10.1074\/jbc.M505291200","volume":"280","author":"AL Theiss","year":"2005","unstructured":"Theiss AL, et al. Tumor necrosis factor (TNF) alpha increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2. J Biol Chem. 2005;280(43):36099\u2013109.","journal-title":"J Biol Chem"},{"issue":"4","key":"10_CR46","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1136\/gut.39.4.532","volume":"39","author":"K Hormi","year":"1996","unstructured":"Hormi K, Lehy T. Transforming growth factor-alpha in vivo stimulates epithelial cell proliferation in digestive tissues of suckling rats. Gut. 1996;39(4):532\u20138.","journal-title":"Gut"},{"issue":"1","key":"10_CR47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1620\/tjem.195.21","volume":"195","author":"S Kumagai","year":"2001","unstructured":"Kumagai S, et al. Platelet-derived growth factor and its receptors are expressed in areas of both active inflammation and active fibrosis in inflammatory bowel disease. Tohoku J Exp Med. 2001;195(1):21\u201333.","journal-title":"Tohoku J Exp Med"},{"issue":"1","key":"10_CR48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000445135","volume":"1","author":"F Rieder","year":"2016","unstructured":"Rieder F, et al. Intestinal fibrosis and liver fibrosis: consequences of chronic inflammation or independent pathophysiology? Inflamm Intest Dis. 2016;1(1):41\u20139.","journal-title":"Inflamm Intest Dis"},{"issue":"Suppl 14","key":"10_CR49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/BF03326410","volume":"37","author":"A Andoh","year":"2002","unstructured":"Andoh A, et al. Intestinal subepithelial myofibroblasts in inflammatory bowel diseases. J Gastroenterol. 2002;37(Suppl 14):33\u20137.","journal-title":"J Gastroenterol"},{"issue":"5","key":"10_CR50","doi-asserted-by":"publisher","first-page":"G677","DOI":"10.1152\/ajpgi.00104.2011","volume":"300","author":"C Fiocchi","year":"2011","unstructured":"Fiocchi C, Lund PK. Themes in fibrosis and gastrointestinal inflammation. Am J Physiol Gastrointest Liver Physiol. 2011;300(5):G677\u201383.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"10_CR51","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.crohns.2008.05.009","volume":"2","author":"F Rieder","year":"2008","unstructured":"Rieder F, Fiocchi C. Intestinal fibrosis in inflammatory bowel disease - current knowledge and future perspectives. J Crohns Colitis. 2008;2(4):279\u201390.","journal-title":"J Crohns Colitis"},{"issue":"8","key":"10_CR52","doi-asserted-by":"publisher","first-page":"407","DOI":"10.12968\/jowc.2013.22.8.407","volume":"22","author":"P Bainbridge","year":"2013","unstructured":"Bainbridge P. Wound healing and the role of fibroblasts. J Wound Care. 2013;22(8):407\u20138, 410-12.","journal-title":"J Wound Care"},{"issue":"3","key":"10_CR53","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0039-6109(05)70566-1","volume":"77","author":"MB Witte","year":"1997","unstructured":"Witte MB, Barbul A. General principles of wound healing. Surg Clin North Am. 1997;77(3):509\u201328.","journal-title":"Surg Clin North Am"},{"issue":"1","key":"10_CR54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/00054725-200102000-00003","volume":"7","author":"IC Lawrance","year":"2001","unstructured":"Lawrance IC, Maxwell L, Doe W. Inflammation location, but not type, determines the increase in TGF-\u03b21 and IGF-1 expression and collagen deposition in IBD intestine. Inflamm Bowel Dis. 2001;7(1):16\u201326.","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10_CR55","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.gastro.2003.07.004","volume":"125","author":"SN Leeb","year":"2003","unstructured":"Leeb SN, et al. Reduced migration of fibroblasts in inflammatory bowel disease: role of inflammatory mediators and focal adhesion kinase. Gastroenterology. 2003;125(5):1341\u201354.","journal-title":"Gastroenterology"},{"issue":"12","key":"10_CR56","first-page":"1491","volume":"11","author":"IC Lawrance","year":"2015","unstructured":"Lawrance IC, et al. Cellular and molecular mediators of intestinal fibrosis. J Crohns Colitis. 2015;11(12):1491\u2013503.","journal-title":"J Crohns Colitis"},{"issue":"4","key":"10_CR57","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/hep.22193","volume":"47","author":"RG Wells","year":"2008","unstructured":"Wells RG. The role of matrix stiffness in regulating cell behavior. Hepatology. 2008;47(4):1394\u2013400.","journal-title":"Hepatology"},{"issue":"9","key":"10_CR58","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/ecco-jcc\/jjv108","volume":"9","author":"A Sonnenberg","year":"2015","unstructured":"Sonnenberg A, Genta RM. Epithelial dysplasia and cancer in IBD strictures. J Crohns Colitis. 2015;9(9):769\u201375.","journal-title":"J Crohns Colitis"},{"issue":"6","key":"10_CR59","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1056\/NEJM196908072810603","volume":"281","author":"SJ Goulston","year":"1969","unstructured":"Goulston SJ, McGovern VJ. The nature of benign strictures in ulcerative colitis. N Engl J Med. 1969;281(6):290\u20135.","journal-title":"N Engl J Med"},{"issue":"1","key":"10_CR60","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3748\/wjg.v20.i1.37","volume":"20","author":"G Bassotti","year":"2014","unstructured":"Bassotti G, et al. Gastrointestinal motility disorders in inflammatory bowel diseases. World J Gastroenterol. 2014;20(1):37\u201344.","journal-title":"World J Gastroenterol"},{"issue":"Suppl 17","key":"10_CR61","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00535-006-1942-7","volume":"42","author":"S Fukudo","year":"2007","unstructured":"Fukudo S. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation. J Gastroenterol. 2007;42(Suppl 17):48\u201351.","journal-title":"J Gastroenterol"},{"issue":"1","key":"10_CR62","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1136\/gut.52.1.84","volume":"52","author":"M Neunlist","year":"2003","unstructured":"Neunlist M, et al. Changes in chemical coding of myenteric neurones in ulcerative colitis. Gut. 2003;52(1):84\u201390.","journal-title":"Gut"},{"issue":"4","key":"10_CR63","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1001\/archsurg.137.4.439","volume":"137","author":"MD Vrees","year":"2002","unstructured":"Vrees MD, et al. Abnormal motility in patients with ulcerative colitis: the role of inflammatory cytokines. Arch Surg. 2002;137(4):439\u201346.","journal-title":"Arch Surg"},{"issue":"4","key":"10_CR64","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1053\/j.gastro.2011.06.074","volume":"141","author":"K Choi","year":"2011","unstructured":"Choi K, et al. Impaired integrity of DNA after recovery from inflammation causes persistent dysfunction of colonic smooth muscle. Gastroenterology. 2011;141(4):1293\u2013301, 1301.e1-3.","journal-title":"Gastroenterology"},{"issue":"12","key":"10_CR65","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.3748\/wjg.v9.i12.2791","volume":"9","author":"JH La","year":"2003","unstructured":"La JH, et al. Visceral hypersensitivity and altered colonic motility after subsidence of inflammation in a rat model of colitis. World J Gastroenterol. 2003;9(12):2791\u20135.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10_CR66","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1053\/j.gastro.2016.09.047","volume":"152","author":"F Rieder","year":"2017","unstructured":"Rieder F, Fiocchi C, Rogler G. Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases. Gastroenterology. 2017;152(2):340\u2013350.e6.","journal-title":"Gastroenterology"},{"key":"10_CR67","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.fct.2013.06.019","volume":"59","author":"PP Trivedi","year":"2013","unstructured":"Trivedi PP, Jena GB. Role of alpha-lipoic acid in dextran sulfate sodium-induced ulcerative colitis in mice: studies on inflammation, oxidative stress, DNA damage and fibrosis. Food Chem Toxicol. 2013;59:339\u201355.","journal-title":"Food Chem Toxicol"}],"container-title":["Fibrostenotic Inflammatory Bowel Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-90578-5_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T14:32:47Z","timestamp":1536071567000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-90578-5_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319905778","9783319905785"],"references-count":67,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-90578-5_10","relation":{},"subject":[],"published":{"date-parts":[[2018]]}}}